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Abstract
Background: Recent evidence suggests that there is a link between metabolic diseases and bacterial populations in the gut.
The aim of this study was to assess the differences between the composition of the intestinal microbiota in humans with
type 2 diabetes and non-diabetic persons as control.
Methods and Findings: The study included 36 male adults with a broad range of age and body-mass indices (BMIs), among
which 18 subjects were diagnosed with diabetes type 2. The fecal bacterial composition was investigated by real-time
quantitative PCR (qPCR) and in a subgroup of subjects (N=20) by tag-encoded amplicon pyrosequencing of the V4 region
of the 16S rRNA gene. The proportions of phylum Firmicutes and class Clostridia were significantly reduced in the diabetic
group compared to the control group (P=0.03). Furthermore, the ratios of Bacteroidetes to Firmicutes as well as the ratios of
Bacteroides-Prevotella group to C. coccoides-E. rectale group correlated positively and significantly with plasma glucose
concentration (P=0.04) but not with BMIs. Similarly, class Betaproteobacteria was highly enriched in diabetic compared to
non-diabetic persons (P=0.02) and positively correlated with plasma glucose (P=0.04).
Conclusions: The results of this study indicate that type 2 diabetes in humans is associated with compositional changes in
intestinal microbiota. The level of glucose tolerance should be considered when linking microbiota with metabolic diseases
such as obesity and developing strategies to control metabolic diseases by modifying the gut microbiota.
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Introduction
Type 2 diabetes is a metabolic disease which primary cause is
obesity-linked insulin resistance. However, some other factors like
mental stress, infection and genetic predisposition might lead to
diabetes as well [1-4]. Both obesity and diabetes are characterized
by a state of chronic low-grade inflammation with abnormal
expression and production of multiple inflammatory mediators
such as tumor necrosis factor and interleukins [5]. Recent studies
based on large-scale 16S rRNA gene sequencing and more limited
techniques, based on quantitative real time PCR (qPCR) and
fluorescent in situ hybridization (FISH), have shown a relationship
between the composition of the intestinal microbiota and
metabolic diseases like obesity and diabetes. For example, levels
of Bifidobacterium significantly and positively correlated with
improved glucose-tolerance and low-grade inflammation in
prebiotic treated-mice [1,6]. Furthermore, the development of
diabetes type 1 in rats was reported to be associated with higher
amounts of Bacteroides ssp. [7]. It has been proposed that the gut
microbiota directed increased monosaccharide uptake from the
gut and instructed the host to increase hepatic production of
triglycerides associated with the development of insulin resistance
[8].
Severalstudies on mice models and in humans provided evidence
that increase in body weight was associated with a larger proportion
ofFirmicutes andrelativelylessBacteroidetes[9-11].In accordance with
theseresults,Zhangandcoworkers[12] demonstrated thatFirmicutes
were significantly decreased in post-gastric-bypass individuals, and
Prevotellaceae highly enriched in obese individuals. The differences in
microbial composition were explained by an increased capacity of
the obesity-associated microbiome to harvest energy from the diet
[13]. Controversial data were recently reported by Schwiertz and
colleagues [14]. They determined lower ratios of Firmicutes to
Bacterodetes in overweight human adults compared to lean controls.
Another study, using weight loss diets, found no proof of the link
between the proportion of Bacteroidetes and Firmicutes and human
obesity [15]. Consequently, the composition of obese microbiome is
still questionable and more scientific evidence is needed to elucidate
the relationship between the gut microbial composition and
metabolic diseases.
Most of the published studies describe the differences between
gut microbiota in obese compared to lean persons, while type 2
PLoS ONE | www.plosone.org 1 February 2010 | Volume 5 | Issue 2 | e9085diabetes is generally considered as an attribute to obesity and thus
far left behind as the focus of research. The objective of this study
was to characterize the composition of fecal microbiota in adults
with diabetes type 2 as compared to non-diabetic controls using
tag-encoded amplicon pyrosequencing of the V4 region of the 16S
rRNA gene and qPCR.
Results
Subjects
Subjects with type 2 diabetes (N=18) and non-diabetic controls
(N=18) were all males at age 31 to 73 years and body mass indices
(BMIs) ranging from 23 to 48 (Table 1). The diabetic group had
elevated concentration of plasma glucose as determined by a
fasting oral glucose tolerance test (OGTT). Subject C17, though
having high plasma glucose, was referred to the non-diabetic
group based on the measurements of baseline glucose and
biochemical analysis of blood samples. The two groups were
comparable with regard to their characteristics.
Characterization of the Intestinal Microbiota by Tag-
Encoded Pyrosequencing
The total number of reads obtained for 20 subjects by V4 16S
rRNA pyrosequencing was 1028955. After applying quality
control and trimming we obtained 382229 high quality sequences
from diabetic persons and 357782 sequences from healthy
controls, accounting for 71.9% of the total reads (Table 2). The
number of sequences varied between the subjects from 10521 to
66999 with a mean of 37000 (SD 16062). The average sequence
length of trimmed sequences was 234 bp.
The mean bacterial diversity, as estimated by Chao1 indices
from the equalized data sets (Table 2), was not different between
the diabetic subjects and the controls, comprising 2287 (SD 587)
and 2363 (SD 1113), respectively. However, the variability of
Chao1 estimates between the diabetic subjects (Chao1 from 1364
to 2939) was lower compared to the controls (Chao1 from 589 to
4010). As shown by the rarefactions curves, bacterial diversity and
richness in diabetic subjects with BMI more than 31 (Figure 1, D2,
D5, D8 and D9) was somewhat higher than in lean diabetics, with
the means Chao1 of 2785 (SD 436) and 1945 (SD 399),
respectively. The same tendency was observed in the control
group (Fig. 1, subjects C4, C6, C7 with BMI .31).
Sequences were distributed among 5 bacterial phyla including
Firmicutes and Bacteroidetes, together harboring on average up to
90% of sequences, as well as phyla Proteobacteria, Actinobacteria and
Verrumicrobia, each accounting for 1–4% of the sequences (Figure 2).
The proportion of Firmicutes was significantly higher (P=0.03) in
the controls (mean 56.4%) compared to the diabetic group (mean
36.8%). Accordingly, phylum Bacteroidetes and Proteobacteria were
somewhat but not significantly enriched in the diabetic group.
Furthermore, ratios of Bacteroidetes to Firmicutes correlated positively
and significantly with the values of plasma glucose determined by
OGTT (R=0.47, P=0.04) and negatively, though not signifi-
cantly, with BMI (R=20.32, P=0.17; Figure 3A, D). Relative
abundances of Actinobacteria and Verrumicrobia were not significantly
different between the groups (Figure 2).
Phylum Bacteroidetes was primarily presented by class Bacteroidetes
that was on average slightly increased in diabetics (44%) compared
to controls (33%; Figure 2). Most of the sequences from Firmicutes
belonged to the class Clostridia, varying from 14 to 72% between
Table 1. Characteristics of the diabetic subjects and controls in the study: age, body mass index (BMI) and plasma glucose
concentration measured by oral glucose tolerance test (OGTT).
Subjects with diabetes type 2 (N=18) Control group (N=18)
Subject ID Age, Years BMI Kg/m
2
OGTT glucose
mmol/l Subject ID Age, Years BMI Kg/m
2
OGTT glucose
mmol/l
D1 40 24 25.8 C1 34 25 4.8
D2 51 48 27.9 C2 54 27 4.2
D3 69 25 13.3 C3 60 24 3.8
D4 62 27 20.6 C4 68 39 3.5
D5 42 34 20.5 C5 39 31 5.5
D6 72 23 22.1 C6 58 33 4.7
D7 53 23 24.7 C7 55 39 4.6
D8 31 43 20.6 C8 52 24 5.4
D9 54 33 19.0 C9 58 27 5.3
D10 52 25 18.1 C10 72 27 5.1
D11 36 36 8.8 C11 70 29 6.5
D12 64 22 12.1 C12 43 25 3.2
D13 76 27 19.3 C13 59 23 5.2
D14 61 28 15.0 C14 68 28 5.6
D15 60 32 22.0 C15 74 23 4.5
D16 65 27 8.8 C16 65 32 4.2
D17 49 31 17.4 C17 64 24 9.2
D18 73 23 18.7 C18 63 24 4.0
Mean (s.d.) 56 (13) 30 (7) 18.6 (5.4) Mean (s.d.) 59 (11) 28 (5) 5.0 (1.3)
doi:10.1371/journal.pone.0009085.t001
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accounting for less than 6% and 1% of the sequences, respectively.
The proportion of Clostridia in diabetics was significantly lower
than in controls (P=0.03; means of 53% versus 34%, respectively)
and showed a tendency to decrease with higher levels of plasma
glucose (R=20.42, P=0.06; Figure 3B). The relative abundance
of class Bacilli was increased in diabetics at close to significant levels
(mean 0.19% versus 0.03% in controls, P=0.06; Figure 2).
Similarly, class Betaproteobacteria, belonging to Proteobacteria, was
highly enriched in subjects with diabetes (mean 2.09% versus
0.81% in controls; P=0.02) and positively correlated (R=0.46,
P=0.04) with plasma glucose (Fig. 3C). The relative abundances
of bacterial genera (see SI Figure S1) were not significantly
different between the groups. However, the proportion of genus
Roseburia negatively correlated with plasma glucose at levels close
to significance (R=20.52, P=0.06; data not shown), whereas the
opposite trend was observed for the genus Prevotella (R=0.32,
P=0.15; data not shown).
As seen from principal component analysis (PCA), a separation
between the diabetic group and the control group at the level of
Table 2. The number of sequences produced and equalized; the number of operational taxonomic units (OTUs) and richness
estimates (Chao1) at 3% distance within fecal samples of the diabetic persons (D1-D10) and controls (C1–C10) as determined by
pyrosequencing of the V4 region of the 16S rRNA gene.
Sample ID Sequences produced Sequences equalized OTUs Chao1 Confidence interval (95%)
D1 41607 20000 1416 2487 2286–2736
D2 36644 20000 1617 2868 2650–3133
D3 49213 20000 934 1494 1364–1663
D4 54663 20000 1396 2337 2161–2554
D5 66097 20000 1776 3023 2814–3274
D6 10521 10521 1140 1773 1643–1937
D7 26874 20000 1022 1605 1472–1777
D8 27581 20000 1415 2161 2016–2340
D9 27768 20000 1985 3127 2939–3352
D10 41261 20000 1233 1971 1823–2157
C1 28126 20000 1846 3049 2851–3286
C 2 42207 20000 1516 2452 2279–2665
C3 30701 20000 2473 4269 4010–4571
C4 55678 20000 1411 2122 1981–2298
C5 27204 20000 1079 1689 1555–1861
C6 48719 20000 1595 2527 2360–2730
C7 22794 20000 2254 3769 3535–4047
C8 17080 17080 824 1184 1094–1304
C9 18274 18274 456 655 589–755
C10 66999 20000 1322 1911 1793–2059
doi:10.1371/journal.pone.0009085.t002
Figure 1. Rarefaction curves. Rarefaction analysis of V4 pyrosequencing tags of the 16S rRNA gene in fecal microbiota from adults with diabetes
type 2 (D1–D10) and non-diabetic controls (C1–C10). Sample codes are the same as in Table 1. Rarefaction curves were constructed at 3% distance
using RDP release 10 (Pyrosequencing pipelines).
doi:10.1371/journal.pone.0009085.g001
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(Figure 4A; 45% and 28% of explained variance, respectively). It
was attributed to Proteobacteria and Actinobacteria in the second
direction (PC2) in combination with Bacteroides versus Firmicutes and
Verrumicrobia in the first direction (PC1). At the level of bacterial
classes the variation was predominantly linked to a higher positive
score for Betaproteobacteria, Bacteroidetes and Bacilli in the diabetic
group, versus Clostridia and Erysipelotrichi in the control group
(Figure 4B). The PCA plots of bacterial families generally
indicated low levels of systematic variation where only 20–30
percent of the variation was explained by successive PCs, and no
distinct clustering was observed (see SI Figure S2A). No association
of the diabetic group with particular bacterial genera was
apparent. Nevertheless, some of the diabetic persons (see SI
Figure S2B, subjects D1, D3, D4, D6, D8, D10) could be
discriminated from most of the controls by genus Prevotella versus
the combination of genera Lachnospiraceae IS, Roseburia and
Subdoligranulum (PC1 50%). PCA of multiple genera showed no
clear grouping of the subjects with diabetes probably due to the
high individual differences masking the systematic variation (data
not shown).
Quantification of the Intestinal Microbiota by qPCR
The total bacterial counts were similar in the diabetic and the
control group having a median values of 10.6 (quartile ranges (QR)
10.1–11.3) and 10.5 (QR 10.0–11.3) log10 bacteria per g stool,
respectively. The estimates of bacterial groups and genera by qPCR
are presented in Figure 5. In diabetic group the median counts of
Bacteroides-Prevotella group (10.2, QR 9.2–10.6), genus Prevotella (8.8,
QR7.6–11.5)andC.leptumsubgroup(9.6,QR9.0–9.7)wereslightly
but not significantly increased compared to the controls by
approximately 0.7 log10 bacteria. Genus Prevotella was assessed in
25 (14 diabetic subjects and 11 controls) out of 36 samples analysed,
whilst for the remaining samples it was below the detection limit of
the applied qPCR assay. The difference in median counts of C.
coccoides-E. rectale, C. coccoides and Lactobacillus groups, and genus
Roseburia between the diabetic persons and controls was less than 0.2
log10 bacteria per g stool. The estimates of Prevotella and Bacteroides-
Prevotella group were in some qPCR assays higher that the counts of
total bacteria. The explanation might be that the primers, used for
quantification of total bacteria, were not universal enough to
amplify all bacterial populations, or alternatively that the group-
specific primers amplified other targets as well. To overcome this
limitation and to assess the differences between the groups of
subjects we used ratios of bacterial counts. The ratios of Bacteroides-
Prevotella to C. coccoides-E. rectale group correlated significantly and
positively (R=0.38; P=0.03) with plasma glucose (Figure 6A) but
not with BMI (R=0.06, P=0.71). Likewise, a positive correlation
withplasma glucose was found forthe ratiosofBacteroides-Prevotella to
C. coccoides subgroup (R=0.46, P,0.01; data nor shown) and for the
Figure 2. Relative abundances of bacterial phyla and classes. Relative abundances (%) of bacteria were determined in feces from human
adults with type 2 diabetes (green triangles, N=10) and non-diabetic controls (blue dots, N=10) by pyrosequencing analysis of the V4 region of the
16S rRNA gene. Mean values are denoted by red crosses and numbers. Values out of scale are shown in brackets.
doi:10.1371/journal.pone.0009085.g002
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Higher ratios were in general related to a reduction in the C.
coccoides-E. rectale and C. coccoides groups.
Discussion
In this study we hypothesized that intestinal microbiota in
humans with type 2 diabetes is different from non-diabetic
persons. The hypothesis was tested on adults with a broad range of
ages and BMIs, using pyrosequencing of the V4 region of the 16S
rRNA gene and qPCR. To our knowledge no related studies on
humans with diabetes type 2 have been published so far.
We demonstrated in this research that type 2 diabetes is
associated with compositional changes in the intestinal microbiota
mostly apparent at phylum and class levels. The relative abundance
of Firmicutes was significantly lower, while the proportion of
Bacteroidetes and Proteobacteria was somewhat higher in diabetic
persons compared to their non-diabetic counterparts. Accordingly,
the ratios of Bacteroidetes to Firmicutes significantly and positively
correlated with reduced glucose tolerance. Assuming that diabetes
and impaired glucose tolerance are linked to obesity, our results are
in agreement with the recent evidence obtained for overweight
persons by Schwiertz and colleagues [14], though contradict with
other studies [11]. Furthermore, based on the assumption above, a
positive correlation between ratios of Bacteroidetes to Firmicutes and
BMI could be expected. However, the reverse tendency was
observed (Figure 3D), indicating that overweight and diabetes are
associated with different groups of the intestinal microbiota.
Bacterial groups that distinguished the diabetic from the non-
diabetic microbiome included Bacteroides-Prevotella group versus
class Clostridia and C. coccoides-E.rectale group, which ratios were
significantly higher in diabetic persons. These results are
Figure 3. Correlation between OGTT or BMI and bacterial estimates by pyrosequencing. Correlation between OGTT plasma glucose and
(A) ratios of Bacteroidetes to Firmicutes, (B) relative abundance of Clostridia, (C) relative abundance of Betaproteobacteria. (D) Correlation between
body mass indices and ratios of Bacteroidetes to Firmicutes. The Spearman Rank probability (P) and correlation (R) are shown in the graphs. Bacterial
abundances were determined by pyrosequencing of the V4 region of the 16S rRNA gene in fecal bacterial DNA from human adults with type 2
diabetes (N=10) and non-diabetic controls (N=10).
doi:10.1371/journal.pone.0009085.g003
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Prevotella spp. related to a strong decrease of metabolic endotox-
emia and inflammation in type 2 diabetes mice [6]. Accordingly, a
significant reduction in Clostridium ssp, C. coccoides and an increase
in the Bacteroides-Prevotella group along with body weight loss have
been observed in human studies [16,17]. The significantly higher
levels of Bacilli and the Lactobacillus group in diabetic subjects
compared to controls in the present study, have recently been
reported in relation to type 2 diabetes in mice models [6] and to
obesity in human adults [17,18]. Genus Lactobacillus represents a
heterogeneous group with well documented immunomodulating
properties [19] and might potentially contribute to chronic
inflammation in diabetic subjects.
The tendency of increased Chao1 diversity concurrently with BMI
observed in this study, might be related to the negative correlation
between BMI and Bacteroidetes/Firmicutes ratios (Figure 3D) as Firmicutes
is a highly diverse division [12]. This observation is, however, in
disagreement with recently published data on the obese twin pairs
showing reduced bacterial diversity in obese individuals [11]. The
reduced individual variation in diversity of the fecal microbiota
observed in the diabetic group compared to the controls probably
reflected the differences in diet, lifestyle or other factors [20] which are
not possible to specify in the present study.
In an obesity study, using mice models, Cani and coworkers
[21] proposed a hypothesis connecting metabolic diseases with the
presence of Gram-negative bacteria in the gut, also offering a likely
Figure 4. PCA plots of bacterial phyla and classes. PCA plots showing the grouping of human adults with type 2 diabetes (m, D1–D10) and
non-diabetic controls (N, C1–C10) according to the abundances of bacterial phyla (A) and classes (B) in the fecal bacterial DNA as determined by
pyrosequencing of the V4 region of the 16S rRNA gene.
doi:10.1371/journal.pone.0009085.g004
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diabetic microbiomes in this study. The intestinal microbiota
across the subjects with type 2 diabetes was relatively enriched
with Gram-negative bacteria, belonging to the phyla Bacteroidetes
and Proteobacteria. The main compounds of outer membranes in
gram-negative bacteria are lipopolysaccharides (LPS), known as
potent stimulators of inflammation, which can exhibit endotoxae-
mia [22]. Consequently, LPS will continue to be produced within
the gut, which might trigger an inflammatory response and play a
role in the development of diabetes.
In conclusion,our data suggest that the levelsof glucose tolerance or
severity of diabetes should be considered while linking microbiota with
obesity and other metabolic diseases in humans. It is especially
important for developing the strategies to modify the gut microbiota in
order to control metabolic diseases, since obesity and diabetes might
be associated with different bacterial populations.
Methods
Subjects and Sample Collection
The study protocol was approved by the Ethical Committee of
Copenhagen and Frederiksberg Municipalities (KF 01-320695)
and performed according to the declaration of Helsinki. Both
written and verbal consent was obtained from the subjects of the
study. The study included 36 males, diagnosed with type 2
diabetes (N=18) or as being non-diabetic (N=18) by their general
practitioner confirmed by OGTT. The OGTT included the
measurements of plasma glucose (mmol/l) at baseline and two
hours after administration of 75 g glucose diluted in 500 ml of
water. The BMIs were calculated from the formula: weight (kg)/
height (m)
2. Subjects’ ages, BMIs (kg/m
2) and 2-hour plasma
glucose concentrations are presented in Table 1. Fecal samples
were kept at 5uC immediately after defecation, brought to the
laboratory within 24 hours and stored at 280uC before analysis.
Extraction of Bacterial DNA from Fecal Samples
Total bacterial DNA was extracted from the fecal samples using
the QIAamp DNA Stool Mini kit (QIAGEN, GmbH, Germany)
according to the manufacturer’s protocol for pathogen detection
with slight modifications [23]. DNA concentration and quality in
the extracts was determined by agarose gel electrophoresis (1%
wt/vol agarose in Tris-acetate-EDTA (TAE) buffer) and with a
NanoDrop 1000 spectrophotometer Thermo Scientific (Saveen
Werner ApS, Denmark).
Figure 5. Box-and-whisker plots of bacterial groups quantified by qPCR. Bacterial groups quantified by SYBR Green qPCR and expressed as
Log10 bacteria per g stool in human adults with type 2 diabetes (black and white boxes; N=18) and non-diabetic controls (grey and white boxes;
N=18). The median counts are presented by numbers. Boxes show the upper (75%) and the lower (25%) percentiles of the data. Whiskers indicate
the highest and the smallest values.
doi:10.1371/journal.pone.0009085.g005
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Tag-encoded amplicon pyrosequencing of fecal DNA was
conducted for 10 persons with type 2 diabetes and 10 controls,
matching in BMI and age. A selection criterion for diabetic
persons was high severity of diabetes as evaluated by OGTT
plasma glucose (Table 1). The primers used for pyrosequencing
were a modified 530F-mod (GCCAGCMGCNGCGGTA; [24])
and 1061R (CRRCACGAGCTGACGAC; [25]) amplifying a
562 bp DNA fragment flanking the V4, V5 and V6 regions of the
16S rRNA gene ([26]; see SI Table S1). Modification of the primer
530F included two bases (TA) added to 39-end in order to increase
primer specificity. The sequence coverage of the forward and
reverse primers was tested using the Probe Match feature at the
Ribosomal Database Project release 10 (RDP 10; http://rdp.cme.
msu.edu; [27]). The DNA concentration was measured with a
NanoDrop spectrophotometer and adjusted to 5 ng/ml for all
samples. PCR amplification (in a volume of 40 ml) was performed
using 1x Phusion HF buffer, 2.5 mM magnesium chloride,
0.2 mM dNTP mixture, 0.8 U Phusion Hot Start DNA
Polymerase (Finnzymes Oy, Espoo, Finland), 0.5 mM of each
primer (TAG Copenhagen A/S, Denmark) and 1 ml diluted DNA
sample. PCR was performed using the following cycle conditions:
an initial denaturation at 98uC for 30 s, followed by 30 cycles of
denaturation at 98uC for 5 s, annealing at 53uC for 20 s,
elongation at 72uC for 20 s, and then a final elongation step at
72uC for 5 min. The PCR products were run on an agarose gel
and purified using the QIAEX II Gel Extraction Kit (QIAGEN).
Second round of PCR was performed as described above, except
that the primers with adapters and tags were used, the number of
cycles was reduced to 10 and the annealing temperature was
increased to 56uC. Addition of adapter and tags specific to each
sample was done using the custom primers with adapter A and 10
tags (see SI Table S1) required for pyrosequencing [24]. The
concentration of the tagged PCR product was determined by
qPCR. The standard DNA used in qPCR was prepared from
Pseudomonas putida and quantified against a standard concentration
of 200 base ssDNA oligo (TAG Copenhagen A/S, Denmark). The
qPCR was performed in a 25 ml volume, using 1x Brilliant buffer
(Stratagene, Cedar Creek, Texas, USA), 0.5 mM of each primer
FLX (forward: GCCTCCCTCGCGCCATCAG and reverse:
GCCTTGCCAGCCCGCTCAG) and 1 ml of diluted PCR
products with tags and adapters. Amplification was conducted
using a Mx-3000 thermocycler (Stratagene) at the following
conditions: an initial denaturation at 95uC for 10 min, followed by
40 cycles of denaturation at 95uC for 30 s, annealing at 60uC for
60 s. Amplicons were then mixed in approximately equal
concentration (5610
7 copies per ml) to ensure equal representation
of each sample. A two-region 454 sequencing run was performed
on a GS FLX Standard PicoTiterPlate (70X75) by using a GS
FLX pyrosequencing system according to the manufacturer’s
instructions (Roche).
Analysis of sequencing data was conducted using Pyrosequen-
cing Pipeline tools at RDP 10 (http://pyro.cme.msu.edu/index.
jsp). The RDP Classifier was used to assign 16S rRNA gene
sequences to taxonomical hierarchy with a confidence threshold of
80%. Bacterial diversity was determined by sampling-based
analysis of operational taxonomic units (OTUs) and showed by
rarefaction curves. Comparison of bacterial richness across the
samples was performed by Chao1 estimate at the distance of 3%,
usually applied to characterize richness at species level [12,28]. As
the Chao1 estimates are dependent on the size of the sequence
libraries, the sample sizes from the different subject we equalized
by random subtraction.
Real-Time qPCR
Bacterial groups in fecal samples from 18 subjects with type 2
diabetes and 18 controls were quantified by qPCR using the 7500
Fast Real-time PCR System (Applied Biosystems, USA) and the
primers shown in Table 3 (TAG Copenhagen A/S, Denmark).
Genus-specific primers for amplification of Prevotella and Roseburia
were designed using 16S rRNA gene sequences from the RDP 10.
Sequences were aligned by the ClustalW software provided by the
European Bioinformatics Institute (http://www.ebi.ac.uk/Tools/
clustalw2/index.html). The target-specific sites were assessed by
‘‘Oligo’’ Primer Analysis Software version 6.71 (Molecular Biology
Insights, Inc., USA). Specificity of the primers was evaluated in
Figure 6. Correlation between OGTT and bacterial estimates by qPCR. Correlation between OGTT plasma glucose and (A) ratios of the
Bacteroides-Prevotella group to C.coccoides-E.rectale group, (B) relative abundance of the Lactobacillus group determined by SYBR Green qPCR assay
in feces from human adults with type 2 diabetes (N=18) and non-diabetic controls (N=18). The Spearman Rank probability (P) and correlation (R) are
shown in the graphs.
doi:10.1371/journal.pone.0009085.g006
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ncbi.nlm.nih.gov/Blast.cgi). Prevotella-specific primers were target-
ing Prevotella falsenii, P. copri, P. nigrescens, P. intermedia, P. pallens, P.
maculosa and P. oris. Primers targeting Roseburia were specific for
species Roseburia faecis, R. hominis, R. intestnalis and R. cecicola.
The qPCR reaction mixture (20 ml) was composed of 0.3 mMo f
each universal primer or 0.5 mM of each specific primer, 1x Power
SYBR Green PCR Master Mix (Applied Biosystems, Calif., USA),
and 4 ml fecal DNA added in 10-fold serial dilutions starting from
100-fold dilution to diminish the effect of inhibitors. The
amplification program consisted of one cycle of 95uC for 10
min, followed by 40 cycles of 95uC for 15 s, and 60uC for 1 min.
Standard curves were constructed for each experiment using 10-
fold serial dilutions of bacterial genomic DNA of known
concentration. Genomic DNA from L. acidophilus NCFM (ATCC
700396) and from Bifidobacterium animalis subsp. lactis (B. lactis) Bi-07
(ATCC SD5220) was extracted with the use of GenElute Bacterial
Genomic DNA Kit (Sigma-Aldrich, Germany) according to the
manufacture’s instructions. DNA from Roseburia intestinalis
DSM14610, Prevotella copri DSM18205, Clostridium leptum DSM
753, Clostridium coccoides DSM935, Clostridium nexile DSM1787
and Bacteroides thetaiotaomicron DSM 2079 was purchased from
DSM collection (Deutsche Sammlung von Mikroorganismen
und Zellkulturen GmbH, Germany). Standard curves were
created according to Applied Biosystems tutorials (http://www3.
appliedbiosystems.com) and normalized to the copy number of the
16S rRNA gene for each species. For the species which copy
number of 16S rRNA operon was not published, it was calculated
by averaging the operon numbers of the closest bacterial taxa from
the ribosomal RNA database rrnDB (http://ribosome.mmg.msu.
edu/rrndb/index.php; [29]). Cell numbers of bacteria in fecal
samples were calculated from the threshold cycle values (Ct) and
expressed as quantity of bacteria per gram feces [30].
Statistical Analysis
PCA plots were generated by Matlab 2008b using in-house
algorithms (http://www.mathworks.com). Differences in bacterial
populations between the diabetic and control groups were assessed
using the two-sided Wilcoxon Rank Sum test (Statistics Online
Computational Resource (SOCR), http://www.socr.ucla.edu/
SOCR.html). Correlation between the variables was computed
by Spearman Rank correlation provided by Free Statistics
Software (version 1.1.23-r4, Office for Research Development
and Education, http://www.wessa.net/). The qPCR results were
graphically presented by Box and Whisker charts (Microsoft Office
Excel 2007) and expressed as medians with quartile ranges
(QR).
Supporting Information
Figure S1 Relative abundances of bacterial genera. Relative
abundances (%) of bacterial genera in feces from human adults
with type 2 diabetes (green triangles, N=10) and non-diabetic
controls (blue dots, N=10) determined by pyrosequencing of the
V4 region of the 16S rRNA gene. Mean values are denoted by
red crosses and numbers. Values out of scale are shown in
brackets.
Found at: doi:10.1371/journal.pone.0009085.s001 (0.28 MB TIF)
Figure S2 PCA plots of bacterial families and genera. PCA plots
showing the grouping of human adults with type 2 diabetes
(triangles, D1-D10) and non-diabetic controls (dots, C1-C10)
according to the abundances of bacterial families (A) and genera
(B) in fecal bacterial DNA as determined by pyrosequencing of the
V4 region of the 16s rRNA gene.
Found at: doi:10.1371/journal.pone.0009085.s002 (0.32 MB
TIF)
Table 3. Primers used in the study for real-time qPCR and size of PCR products.
Target organism Primer
a Sequence (59to 39) PCR productbp Reference
Clostridium coccoides-Eubacteria rectale group ClEubF CGGTACCTGACTAAGAAGC 429 [31]
ClEubR AGTTTYATTCTTGCGAACG
Clostridium leptum subgroup CleptF GCACAAGCAGTGGAGT 239 [32]
CleptR CTTCCTCCGTTTTGTCAA
Clostridium coccoides subgroup CcocF AAATGACGGTACCTGACTAA 440
CcocR CTTTGAGTTTCATTCTTGCGAA
Roseburia
b RosF TACTGCATTGGAAACTGTCG 230 This study
RosR CGGCACCGAAGAGCAAT
Bacteroides-Prevotella group BacF GAAGGTCCCCCACATTG 410 [33]
BacR CAATCGGAGTTCTTCGTG
Prevotella
c PrevF CACCAAGGCGACGATCA 283 This study
PrevR GGATAACGCCYGGACCT
Lactobacillus group LacF AGCAGTAGGGAATCTTCCA 341 [34]
LacR CACCGCTACACATGGAG
Bifidobacterium BifF GCGTGCTTAACACATGCAAGTC 126 [35]
BifR CACCCGTTTCCAGGAGCTATT
All bacteria UnivF TCCTACGGGAGGCAGCAGT 466 [36]
UnivR GACTACCAGGGTATCTAATCCTGTT
aPrimers F (forward) and R (reverse) targeting the 16S rRNA gene.
bPrimers targeting Roseburia species: R. faecis, R. hominis, R. intestnalis and R. cecicola.
cPrimers targeting Prevotella species: P. falsenii, P. copri, P. nigrescens, P. intermedia, P. pallens, P. maculosa and P. oris.
doi:10.1371/journal.pone.0009085.t003
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PLoS ONE | www.plosone.org 9 February 2010 | Volume 5 | Issue 2 | e9085Table S1 Primers, adaptor and sample-specific barcodes used in
the study for tag-encoded amplicon pyrosequencing of the V4
region of the 16S rRNA gene.
Found at: doi:10.1371/journal.pone.0009085.s003 (0.03 MB
DOC)
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